N
Natixis Portfolio holdings
AUM
$20.1B
1-Year Return
17.51%
Natixis is a global financial services business line of Groupe BPCE, offering a range of services including corporate and investment banking, asset management, insurance, and wealth management, with a focus on green and sustainable finance.
This Quarter Return
+15.58%
1 Year Return
+17.51%
3 Year Return
+106.1%
5 Year Return
+162.29%
10 Year Return
+380.38%
AUM
$18B
AUM Growth
+$4.78B
(+36%)
Cap. Flow
+$3.26B
Cap. Flow
% of AUM
18.15%
Top 10 Holdings %
Top 10 Hldgs %
39.42%
Holding
1,254
New
248
Increased
345
Reduced
296
Closed
273
Top Buys
| 1 |
Microsoft
MSFT
|
+$563M |
| 2 |
Apple
AAPL
|
+$463M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$442M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$315M |
| 5 |
NVIDIA
NVDA
|
+$262M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$663M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$104M |
| 3 |
Prologis
PLD
|
+$102M |
| 4 |
Cigna
CI
|
+$90.1M |
| 5 |
Procter & Gamble
PG
|
+$82.8M |
Sector Composition
| 1 | Technology | 38.81% |
| 2 | Consumer Discretionary | 10.31% |
| 3 | Financials | 9.02% |
| 4 | Healthcare | 7.94% |
| 5 | Communication Services | 4.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
651
Teladoc Health
TDOC
$1.38B
| $300K | ﹤0.01% |
+19,898
| New | +$300K |
|
652
Kinross Gold
KGC
$27.3B
| $299K | ﹤0.01% |
48,730
+41,675
| +591% | +$255K |
|
653
Biomea Fusion
BMEA
$111M
| $297K | ﹤0.01% |
19,500
+7,700
| +65% | +$117K |
|
654
Darling Ingredients
DAR
$4.94B
| $296K | ﹤0.01% |
6,360
-153,277
| -96% | -$7.13M |
|
655
Itron
ITRI
$5.49B
| $294K | ﹤0.01% |
3,181
-3,082
| -49% | -$285K |
|
656
United States Oil Fund
USO
$912M
| $291K | ﹤0.01% |
3,700
| – | – |
|
|
NGM
657
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $288K | ﹤0.01% |
+181,366
| New | +$288K |
|
|
ENV
658
DELISTED
ENVESTNET, INC.
ENV
| $276K | ﹤0.01% |
4,767
+544
| +13% | +$31.5K |
|
659
Brookfield
BN
$99B
| $275K | ﹤0.01% |
+6,558
| New | +$275K |
|
660
TC Energy
TRP
$53.9B
| $270K | ﹤0.01% |
+6,725
| New | +$270K |
|
|
DSL
661
DoubleLine Income Solutions Fund
DSL
$1.44B
| $270K | ﹤0.01% |
21,227
+77
| +0.4% | +$978 |
|
662
Globalstar
GSAT
$4.68B
| $268K | ﹤0.01% |
+12,174
| New | +$268K |
|
663
Arthur J. Gallagher & Co
AJG
$76.7B
| $266K | ﹤0.01% |
1,065
-46,360
| -98% | -$11.6M |
|
664
Rhythm Pharmaceuticals
RYTM
$6.63B
| $262K | ﹤0.01% |
6,050
-74,450
| -92% | -$3.23M |
|
665
Martin Marietta Materials
MLM
$37.8B
| $260K | ﹤0.01% |
423
-3,117
| -88% | -$1.91M |
|
|
ITCI
666
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $258K | ﹤0.01% |
3,733
+2,329
| +166% | +$161K |
|
667
EnerSys
ENS
$3.92B
| $257K | ﹤0.01% |
2,724
-555
| -17% | -$52.4K |
|
668
iShares MSCI USA Value Factor ETF
VLUE
$7.19B
| $256K | ﹤0.01% |
2,361
-1,128
| -32% | -$122K |
|
669
Aurinia Pharmaceuticals
AUPH
$1.62B
| $254K | ﹤0.01% |
50,717
-27,897
| -35% | -$140K |
|
670
Dover
DOV
$24.4B
| $252K | ﹤0.01% |
1,425
+1,365
| +2,275% | +$242K |
|
671
Vanguard Value ETF
VTV
$143B
| $249K | ﹤0.01% |
1,530
-732
| -32% | -$119K |
|
672
Century Communities
CCS
$2.02B
| $247K | ﹤0.01% |
+2,564
| New | +$247K |
|
673
ASML
ASML
$317B
| $238K | ﹤0.01% |
245
-733
| -75% | -$711K |
|
674
Sixth Street Specialty
TSLX
$2.33B
| $237K | ﹤0.01% |
11,060
-77
| -0.7% | -$1.65K |
|
675
iShares MSCI EAFE ETF
EFA
$66.6B
| $237K | ﹤0.01% |
+2,963
| New | +$237K |
|